Track topics on Twitter Track topics that are important to you
(Reuters) - The U.S. Food and Drug Administration on Monday approved a new treatment for patients with acute bacterial skin infections, made by privately held Melinta Therapeutics.
Original Article: FDA approves new antibiotic to treat serious skin infectionsNEXT ARTICLE
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...